Anesthetic drugs & techniques

Postoperative oxygenation assessed by SpO2/FiO2 ratio and respiratory complications after reversal of neuromuscular block with Sugammadex or neostigmine: A retrospective cohort study

J Clin AnesthPublished Retrospective cohort study

Main finding · Minimum SpO2/FiO2 ratioResult — go to the resultDifference in means −3.5 95% CI −5.3 to −1.7

Authors' conclusion

Postoperative minimum SpO2/FiO2 ratio during PACU admission was similar after reversal of neuromuscular block by sugammadex and neostigmine. Reversal with sugammadex was associated with more pulmonary complications, but most were minor and of little consequence.

Study context

Population
Adults after non-cardiothoracic surgery given neostigmine or sugammadex, PACU of a tertiary care hospital
Participants
71,457 cases
Exposure
Sugammadex vs neostigmine for reversal of NMB
  • Sugammadexn = 10,708
  • Neostigminen = 60,749reference
Outcome
Lowest SpO2/FiO2 ratio in the PACU
Methodological detailspropensity weighting, single tertiary care hospital
  • Propensity weighting
  • Single tertiary care hospital

Main finding

Minimum SpO2/FiO2 ratio

Difference in means

−3.5

95% CI −5.3 to −1.7

P = 0.0002

By group

Sugammadex

301

mean · SD 77

Neostigmine

303

mean · SD 71

Sugammadex vs Neostigmine
difference in means −3.5 (95% CI −5.3 to −1.7); P = 0.0002

As reported in the abstract

Observational data: associations, not effects.

Safety

Composite postoperative pulmonary complications · secondary outcome

number-needed-to-be-exposed 136 (83–330) · P = 0.0005

Composite postoperative pulmonary complications

Main contributing components: new bronchospasm or exacerbation of obstructive pulmonary disease

Original publication

Postoperative oxygenation assessed by SpO2/FiO2 ratio and respiratory complications after reversal of neuromuscular block with Sugammadex or neostigmine: A retrospective cohort study. J Clin Anesth. Published 5 May 2023. doi:10.1016/j.jclinane.2023.111138

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.